Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Hypercobalaminaemia is usually asymptomatic and discovered incidentally during blood tests
Payers do not reimburse based on what was done
Often depleted by birth control pills
Research-grade GHK-Cu pricing varies by vial size, purity certification depth, and supplier overhead
What this means in practice: Compounding pharmacies that halted GHK-Cu production in 2023 can begin preparing to restock (once July guidance is finalized) Clinicians prescribing peptide protocols will have legitimate, pharmaceutical-grade sourcing options again Patients who've been sourcing from unregulated channels will have access to properly tested product Quality and safety will improve compounded products from licensed facilities must meet USP standards for purity and sterility What This Doesn't Mean This is not FDA approval
)
